Lars Ekman, M.D., Ph.D.

Dr. Ekman has served as a member of our board of directors since November 2003. He recently served as executive vice president and president of global research and development of Elan Pharmaceuticals for seven years. Prior to joining Elan, Dr. Ekman served as executive vice president, R&D, at Schwarz Pharma AG, a pharmaceutical company. Dr. Ekman has also served in a variety of senior scientific and clinical roles at Pharmacia Corp., which was acquired by Pfizer, Inc., a pharmaceutical company, for 14 years. Dr. Ekman is a board certified surgeon with a Ph.D. in experimental biology and has held several clinical and academic positions in both the United States and Europe. He obtained his doctorate degree and doctorate of medicine degree from the University of Gothenburg, Sweden. Dr. Ekman also serves on the board of directors at Elan Pharmaceuticals, Amarin Corp., InterMune, Inc., and Cebix, Inc.